You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Carisoprodol - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for carisoprodol and what is the scope of patent protection?

Carisoprodol is the generic ingredient in three branded drugs marketed by Mylan Speciality Lp, Able, Accelrx Labs, Aurobindo Pharma, Chartwell Rx, Epic Pharma Llc, Hikma Intl Pharms, MLV, Natco, Nostrum Labs Inc, Novast Labs, Orient Pharma Co Ltd, Oxford Pharms, Pioneer Pharms, Sandoz, Sciegen Pharms Inc, Strides Pharma, Sun Pharm Inds Ltd, Sun Pharm Industries, Wanbang Biopharms, Watson Labs, Watson Labs Teva, Wilshire Pharms Inc, and Schering, and is included in twenty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for carisoprodol. Twenty-seven suppliers are listed for this compound.

Summary for carisoprodol

US Patents:	0
Tradenames:	3
Applicants:	24
NDAs:	26
Drug Master File Entries:	16
Finished Product Suppliers / Packagers:	27
Raw Ingredient (Bulk) Api Vendors:	83
Clinical Trials:	4
Patent Applications:	7,081
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for carisoprodol
What excipients (inactive ingredients) are in carisoprodol?	carisoprodol excipients list
DailyMed Link:	carisoprodol at DailyMed

See drug prices for carisoprodol

Drug Sales Revenue Trends for carisoprodol

See drug sales revenues for carisoprodol

Recent Clinical Trials for carisoprodol

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Ache Laboratorios Farmaceuticos S.A.	Phase 3
Pharmagenix Projetos em Medicina Farmacêutica Ltda.	Phase 3
Farmoquimica S.A.	Phase 3

See all carisoprodol clinical trials

Pharmacology for carisoprodol

Drug Class	Muscle Relaxant
Physiological Effect	Centrally-mediated Muscle Relaxation

Medical Subject Heading (MeSH) Categories for carisoprodol

Muscle Relaxants, Central

US Patents and Regulatory Information for carisoprodol

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Nostrum Labs Inc	CARISOPRODOL	carisoprodol	TABLET;ORAL	207237-001	May 11, 2017	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Schering	RELA	carisoprodol	TABLET;ORAL	012155-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Wanbang Biopharms	CARISOPRODOL	carisoprodol	TABLET;ORAL	081025-001	Apr 13, 1989	AA	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.